DigestRedComo funciona
Red
/
Empresas
AC
No verificado

AC Immune SA

Sobre qué escribimos

Anuncios brevesBiotecnologíaGestión empresarial/Administración de EmpresasMedicina Salud BienestarPublicidad/Marketing/Medios de comunicación/Comunicación

16 Comunicados de prensa

Ver todos los comunicados de prensa
11/11/2025
Biotecnología
AC Immune to Present at the Jefferies 2025 London Healthcare Conference
Fuente
AC Immune SA
Editor
GLOBENEWSWIRE
1.00
0
04/11/2025
Biotecnología
Gestión empresarial/Administración de Empresas
AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Fuente
AC Immune SA
Editor
GLOBENEWSWIRE
1.00
0
28/10/2025
Biotecnología
Anuncios breves
AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board
Fuente
AC Immune SA
Editor
GLOBENEWSWIRE
1.00
0
24/10/2025
Biotecnología
Publicidad/Marketing/Medios de comunicación/Comunicación
Medicina Salud Bienestar
First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine
Fuente
AC Immune SA
Editor
GLOBENEWSWIRE
1.00
0
25/09/2025
Biotecnología
Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine
Fuente
AC Immune SA
Editor
GLOBENEWSWIRE
1.00
0
04/09/2025
Biotecnología
Anuncios breves
Finanzas
AC Immune Sharpens Pipeline Focus with Operational Efficiencies Extending Cash Runway
Fuente
AC Immune SA
Editor
GLOBENEWSWIRE
1.00
0
05/08/2025
Biotecnología
Gestión empresarial/Administración de Empresas
Anuncios breves
Publicidad/Marketing/Medios de comunicación/Comunicación
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
Fuente
AC Immune SA
Editor
GLOBENEWSWIRE
1.00
0
30/04/2025
Biotecnología
Gestión empresarial/Administración de Empresas
Medicina Salud Bienestar
Publicidad/Marketing/Medios de comunicación/Comunicación
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
Fuente
AC Immune SA
Editor
GLOBENEWSWIRE
1.00
0
02/04/2025
Biotecnología
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
Fuente
AC Immune SA
Editor
GLOBENEWSWIRE
1.00
0
25/03/2025
Biotecnología
Medicina Salud Bienestar
AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025
Fuente
AC Immune SA
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0